Insurances & Business

News Economy Business Investment Banks Credits

Bristol-Myers Could Be an Acquisition Target: Bernstein

(Reuters) - Drugmaker Bristol-Myers Squibb Co <BMY.N> could
be an acquisition target as the industry gets closer to losing
exclusivity on several leading drugs, said a Sanford C.
Bernstein analyst, who upgraded the stock to “outperform” from
“market-perform.”

Leave a Reply »»

Similar/Related/News: